Inhibition of the tissue factor-thrombin pathway limits infarct size after myocardial ischemia-reperfusion injury by reducing inflammation

American Journal of Pathology

Volumn 157, Issue 6, 2000, Pages 1849-1862

  Erlich, Jonathan H ^a   Boyle, Edward M ^b   Labriola, Joanne ^a   Kovacich, J Craig ^a   Santucci, Richard A ^a   Fearns, Colleen ^a   Morgan, Elizabeth N ^b   Yun, Wang ^b   Luther, Thomas ^c   Kojikawa, Osamu ^b   Martin, Thomas R ^b   Pohlman, Timothy H ^b   Verrier, Edward D ^b   Mackman, Nigel ^a  

^a SCRIPPS RESEARCH INSTITUTE   (United States)

^b UNIVERSITY OF WASHINGTON   (United States)

^c DRESDEN UNIVERSITY OF TECHNOLOGY   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

HIRUDIN; INTERLEUKIN 8; TISSUE FACTOR PATHWAY INHIBITOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; BLOOD CLOTTING; CELL ACTIVATION; CELL INFILTRATION; CELL ULTRASTRUCTURE; CONTROLLED STUDY; ENDOTHELIUM CELL; FIBRIN DEPOSITION; HEART INFARCTION; HEART INFARCTION SIZE; HEART MUSCLE ISCHEMIA; IMMUNOHISTOCHEMISTRY; IN SITU HYBRIDIZATION; INFLAMMATION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN LOCALIZATION; RABBIT; REPERFUSION INJURY; SARCOLEMMA;

EID: 0033639115     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64824-9     Document Type: Article

References (56)

1. Progression of myocardial necrosis during reperfusion of ischemic myocardium
2. Inflammation in the course of early myocardial ischemia
3. Cytokine mRNA expression in postischemic/reperfused myocardium
4. Coronary endothelial and cardiac protective effects of a monoclonal antibody to intercellular adhesion molecule-1 in myocardial ischemia and reperfusion
5. Thrombin potently stimulates cytokine production in human vascular smooth muscle cells but not in mononuclear phagocytes
6. Complement C5a, TGF-beta 1, and MCP-1, in sequence, induce migration of monocytes into ischemic canine myocardium within the first one to five hours after reperfusion
7. Evidence for decreased coronary flow reserve in viable postischemic myocardium
8. Leukocyte capillary plugging in myocardial ischemia and reperfusion in the dog
9. The structural biology of expression and function of tissue factor
10. Selective cellular expression of tissue factor in human tissues
11. Localization of tissue factor in the normal vessel wall and in the atherosclerotic plaque
12. Comparison of plasma tissue factor levels in unstable and stable angina pectoris
13. Monocyte tissue factor-like activity in post myocardial infarction patients
14. Procoagulant inflammatory responses of monocytes after direct balloon angioplasty in acute myocardial infarction
15. Lethal E. coli septic shock is prevented by blocking tissue factor with monoclonal antibody
16. Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome
17. Glomerular tissue factor expression in crescentic glomerulonephritis. Correlations between antigen, activity, and mRNA
18. Proteinase-activated receptors: Novel mechanisms of signaling by serine proteases
19. Molecular cloning of a functional thrombin receptor reveals a novel proteolytic mechanism of receptor activation
20. Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation
21. Thrombin induces endothelial type II activation in vitro: IL-1 and TNF-alpha-independent IL-8 secretion and E-selectin expression
22. Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: A mechanism for stabilizing neutrophil adhesion
23. Effects of tissue factor induced by oxygen free radicals on coronary flow during reperfusion
24. Myocardial protective effects of adenosine. Infarct size reduction with pretreatment and continued receptor stimulation during ischemia
25. Hirudin reduces tissue factor expression in neointima after balloon injury in rabbit femoral and porcine coronary arteries
26. Pretreatment of rabbits with either hirudin, ancrod, or warfarin significantly reduces the immediate uptake of fibrinogen and platelets by the deendothelialized aorta wall after balloon-catheter injury in vivo
27. Gerinnungsphysiologische schnellmethode zur bestimmung des fibrinogens
28. Inhibition of interleukin-8 blocks myocardial ischemia-reperfusion injury
29. Signal-induced site-specific phosphorylation targets IκBα to the ubiquitin-proteosome pathway
30. Conservation of tissue factor primary sequence among three mammalian species
31. A sensitive immunoassay to detect the α-chemokine GRO in rabbit blood and lung fluids
32. Sensitive and specific immunoassays to detect rabbit IL-8 and MCP-1: Cytokines that mediate leukocyte recruitment to the lungs
33. Murine tissue factor gene expression in vivo: Tissue and cell specificity and regulation by lipopolysaccharide
34. Detection of early myocardial infarction by the acid fuchsin staining technique
35. Lipopolysaccharide induction of tissue factor expression in rabbits
36. Monoclonal antibodies to a synthetic fibrin-like peptide bind to human fibrin but not fibrinogen
37. Immunohistochemical detection of tissue factor (TF) on paraffin sections of routinely fixed human tissue
38. Functional implications of tissue factor localization to cell-cell contacts in myocardium
39. Role of tissue factor in adhesion of mononuclear phagocytes to and trafficking through endothelium in vitro
40. Functional coronary microvascular injury evident as increased permeability due to brief ischemia and reperfusion
41. Microvasculature sparing with controlled reperfusion of ischemic myocardium
42. Recombinant human antithrombin III improves survival and attenuates inflammatory responses in baboons lethally challenged with Escherichia coli
43. Protease-activated receptor 1 mediates thrombin-dependent, cell-mediated renal inflammation in crescentic glomerulonephritis
44. Antibody to CD-18 exerts endothelial and cardiac protective effects in myocardial ischemia and reperfusion
45. Myocardial ischemia-reperfusion injury in CD18- and ICAM-1-deficient mice
46. Reocclusion after thrombolysis: A problem solved by hirudin?
47. Comparison of the effects of the thrombin inhibitor r-hirudin in four animal models of neointima formation after arterial injury
48. Effect of thrombin inhibition on the dynamics of thrombolysis and on platelet function during thrombolytic therapy
49. Effects of recombinant hirudin (lepirudin) compared with heparin on death, myocardial infarction, refractory angina, and revascularization procedures in patients with acute myocardial ischemia without ST elevation: A randomized trial
50. Angiographic dose-finding study with r-hirudin (HBW 023) for the improvement of thrombolytic therapy with streptokinase (HIT-SK). Interim results
51. Recombinant hirudin (HBW 023) prevents troponin T release after coronary angioplasty in patients with unstable angina
52. Safety observations from the pilot phase of the randomized r-hirudin for improvement of thrombolysis (HIT-III) study
53. Antithrombotic effect of a monoclonal antibody against tissue factor in a rabbit model of platelet-mediated arterial thrombosis
54. A monoclonal antibody against rabbit tissue factor inhibits thrombus formation in stenotic injured rabbit carotid arteries
55. Monoclonal antibody against tissue factor shortens tissue plasminogen activator lysis time and prevents reocclusion in a rabbit model of carotid artery thrombosis
56. Inhibition of endotoxin-induced activation of coagulation and fibrinolysis by pentoxifylline or by a monoclonal anti-tissue factor antibody in chimpanzees